A review of the evidence for the use of metformin in the treatment of metabolic syndrome caused by antipsychotics

Psychiatria Danubina

Volumn 27, Issue , 2015, Pages S489-S491

  Jesus, Cátia ^a   Jesus, Inês ^a   Agius, Mark ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN; NEUROLEPTIC AGENT;

ADULT; CHEMICALLY INDUCED; DRUG EFFECTS; EVIDENCE BASED MEDICINE; HUMAN; LIFESTYLE; MALE; METABOLIC SYNDROME X; MULTIMODALITY CANCER THERAPY; OFF LABEL DRUG USE; UNITED KINGDOM; WEIGHT GAIN;

ADULT; ANTIPSYCHOTIC AGENTS; COMBINED MODALITY THERAPY; ENGLAND; EVIDENCE-BASED MEDICINE; HUMANS; LIFE STYLE; MALE; METABOLIC SYNDROME X; METFORMIN; OFF-LABEL USE; WEIGHT GAIN;

EID: 84952770749     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (0)